DUBLIN--(BUSINESS WIRE)--The "Global Cardiac Restoration Systems Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.
Analysts have predicted that the cardiac restoration systems market will register a CAGR of over 5% by 2023.
CVDs are a class of diseases that affect the heart and blood vessels with conditions such as coronary heart disease, stroke, peripheral arterial disease, and aortic disease. They are usually caused due to the high risk of blood clots and fatty deposition in arteries. Blockage of the blood flow into the heart valve leads to regurgitation and stenosis.
The increasing number of mitral valve regurgitation, mitral valve stenosis, and heart failure cases, where the heart cannot pump enough blood and oxygen to other parts of the body, is driving the market growth. Hence, the demand for cardiovascular restoration devices is expected to increase to treat the damaged and diseased heart valves, which, in turn, drives the market growth.
Market Overview
Growing medical tourism in emerging economies
Medical tourism refers to patients traveling to countries such as Singapore, Malaysia, Thailand, and India to obtain medical treatment with high-quality healthcare, affordability, and accessibility benefits. Medical tourism is a booming industry, as each medical expertise is focused on offering niche services to attract foreign patients. The rise in quality of medical services and infrastructure in developing economies is a contributor to the growth of medical tourism, which propels the growth of the global cardiac restoration systems market during the forecast period.
Increasing number of product recalls
A product recall is a process of retrieving defective cardiac restoration systems from consumers with compensation. Product recalls tending to occur when there is a manufacturing defect in the product, which causes potential health-related risks to consumers. The increasing number of products recalls by manufacturers can slow down the launch of products in the market, affecting the sales and revenues of vendors, which, in turn, hinders the global cardiac restoration systems market growth.
Competitive Landscape
The market appears to be fairly concentrated. The presence of few companies including Abbott and BioVentrix Inc., the competitive environment is quite intense. Vendors in the global cardiac restoration systems market are focused on implementing developmental strategies such as M&A and high R&D investments to improve their market share and expand their presence globally.
CryoLife Inc., Edwards Lifesciences Corp., NeoChord Inc., and Xeltis AG are some of the major companies covered in this report.
Key Topics Covered:
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
- Preface
- Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 04: MARKET SIZING
- Market definition
- Market sizing 2018
- Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
- Market segmentation by product
- Comparison by product
- Mitral valve restoration systems - Market size and forecast 2018-2023
- Left ventricular restoration systems - Market size and forecast 2018-2023
- Market opportunity by product
PART 07: MARKET SEGMENTATION BY END-USER
- Market segmentation by end-user
- Comparison by end-user
- Hospitals - Market size and forecast 2018-2023
- ASCs - Market size and forecast 2018-2023
- Others - Market size and forecast 2018-2023
- Market opportunity by end-user
PART 08: CUSTOMER LANDSCAPE
PART 09: GEOGRAPHIC LANDSCAPE
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2018-2023
- Europe - Market size and forecast 2018-2023
- Asia - Market size and forecast 2018-2023
- ROW - Market size and forecast 2018-2023
- Key leading countries
- Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
PART 12: MARKET TRENDS
- Development of mitral valve restoration systems with tissue engineering approach
- High R&D investments and M&A activities
- Growing awareness about cardiac restoration systems
PART 13: VENDOR LANDSCAPE
- Overview
- Landscape disruption
PART 14: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Abbott
- BioVentrix Inc.
- CryoLife Inc.
- Edwards Lifesciences Corp.
- NeoChord Inc.
-
Xeltis AG
For more information about this report visit https://www.researchandmarkets.com/r/9s2xvv
